SAN FRANCISCO--(BUSINESS WIRE)--Klue, a digital health company focused on behavior tracking and positive change, announces its platform’s expansion to Type 1 Diabetes (T1D). Klue is already known for its gesture sensing and analytics technology that promotes mindful eating and proper hydration. Now, it is ready to branch out in diabetes.
Leveraging patented technology to create never-seen-before capabilities in the realm of treating T1D, Klue’s software unlocks solutions that will be life-changing for patients who have had a lifetime of daily injections and blood sugar monitoring.
Intuitive and proactive, Klue’s fine motor artificial intelligence technology detects high impact moments and allows individuals to better manage their health, all based on insights that are captured automatically and non-intrusively from analyzing their wrist movements. Klue then coaches and engages users around those “in-the-moment” events, for example by sending them bolus reminders. Klue’s early meal detection capabilities and unique insights into eating behaviors are critical components towards the realization of the holy grail; fully autonomous artificial pancreas systems.
Klue invites companies, researchers and developers in the T1D space to make use of its groundbreaking autonomous meal detection capabilities and unique insights into user eating behaviors to roll out new, innovative solutions. Its platform APIs allow seamless integration with third-party applications and platforms.
With its expansion into the T1D arena, Klue is adding a mealtime medication reminder to its suite of turnkey engagement modules. “We are here to help people live healthier and happier lives. We believe that the future of healthcare delivery will thrive on personal, in-the-moment interactions centered around times of high impact,” says Katelijn Vleugels, Founder and CEO of Klue. “The introduction of a reminder module for mealtime insulin administration is another important step in the realization of that vision.”
The module, specifically designed for individuals with T1D, works seamlessly with hardware such as the Apple Watch. The module also features automated text messaging, keeping caregivers connected and offering peace of mind for loved ones who are concerned.
“I am excited about the potential of Klue’s early meal detection capabilities to advance Type 1 Diabetes research and reduce the burden of diabetes,” says Dr. Marc Breton, Associate Professor at the UVA Center for Diabetes Technology. “Missed pre-meal insulin boluses are a leading contributor to poor glycemic control and Klue’s real-time detection could be beneficial to many people with type 1 diabetes. I am most excited about the prospect of using Klue’s technology within a fully autonomous closed-loop artificial pancreas system. Automated real-time information of a patient’s eating behavior, coupled with novel control algorithms, may very well enable a true ‘set and forget’ closed loop insulin delivery system. This would be a game changer in decreasing the daily burden of diabetes and achieving optimal glycemic control for people with T1D.”
Klue will be showcasing its new offering at 3:30 pm on November 2 at the 2018 DiabetesMine™ D-Data ExChange — a meeting of phenomenal minds focused on fostering and accelerating tech-forward solutions for T1D.
Individuals with Type 1 diabetes are invited to try out their new bolus reminder module in the Klue Health App for the Apple watch ahead of general availability! Interested? You can sign up here https://goklue.com/t1d. Trial spots are limited and are offered on a first come, first serve basis.
Klue is a technology company developing a groundbreaking operating system for behavior change. Initially focused on the ability to detect when and how a user eats and drinks, Klue is building a platform that elevates the more important consumption patterns and enables partners to create more insightful, real-time engagements that enhance the outcomes of their existing paradigms. For more information, please visit http://goklue.com/.